ESC & iPSC News 15.11 March 25, 2020 | |
| |
TOP STORYInvestigators showed that transient expression of nuclear reprogramming factors, mediated by expression of mRNAs, promoted a rapid and broad amelioration of cellular aging, including resetting of epigenetic clock, reduction of the inflammatory profile in chondrocytes, and restoration of youthful regenerative response to aged, human muscle stem cells, in each case without abolishing cellular identity. [Nat Commun] Full Article | Press Release | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Researchers showed that the mutation rate in two human ESC lines derived and banked for clinical application was low and not substantially affected by culture with Rho kinase inhibitor, commonly used in their routine maintenance. [Nat Commun] Full Article O-GlcNAcylation Regulates the Methionine Cycle to Promote Pluripotency of Stem Cells Blocking glycosylation of adenosylhomocysteinase decreased the ratio of S-adenosylmethionine versus S-adenosylhomocysteine, reduced the level of H3K4me3, and poised mouse ESC for differentiation. [Proc Natl Acad Sci USA] Abstract Researchers report the essential function of two murine pumilio (Pum) proteins, Pum1 and Pum2, in ESCs and early embryogenesis. Pum1/2 double-mutant ESCs displayed severely reduced self-renewal and differentiation, and Pum1/2 double-mutant mice were developmentally delayed at the morula stage and lethal by embryonic day 8.5. [Proc Natl Acad Sci USA] Abstract Scientists identified an extra-embryonic origin of potently cytotoxic natural killer cells, suggesting that ontogenic origin was a relevant factor in designing human PSC-derived adoptive immunotherapies. [Dev Cell] Full Article | Graphical Abstract Researchers found that human iPSC (hiPSC)-derived ocular cell types exhibited unique adhesion specificities and growth characteristics on distinct E8 fragments of laminin isoforms (LNE8s): hiPSC-derived corneal epithelial cells (iCECs) and other non-CECs rapidly adhered preferentially to LN332/411/511E8 and LN211E8, respectively, through differential expression of laminin-binding integrins. [Stem Cell Reports] Full Article Investigators examined the distribution of pluripotency transcription factors Oct4 and Sox2 in the nucleus of ESCs and inquired whether their organization changed during early differentiation stages preceding their downregulation. [Sci Rep] Full Article The authors demonstrated reduced levels of the mutant aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) and phosphodiesterase 6 (PDE6) proteins in patient organoids, corroborating the findings in animal models; however, patient-derived organoids maintained retinal cell cytoarchitecture despite significantly reduced levels of AIPL1. [Sci Rep] Full Article Role of RB1 in Human Embryonic Stem Cell-Derived Retinal Organoids To study the role of retinoblastoma 1 (RB1) in early human retinal development and tumor formation, investigators generated retinal organoids from CRISPR/Cas9-derived RB1-null human ESCs. They showed that RB was abundantly expressed in retinal progenitor cells in retinal organoids and loss of RB1 promoted S-phase entry. [Dev Biol] Abstract | Graphical Abstract Modeling Human Cytomegalovirus-Induced Microcephaly in Human iPSC-Derived Brain Organoids Scientists showed that infection of human iPSC-derived brain organoids by a “clinical-like” human cytomegalovirus strain resulted in reduced brain organoid growth, impaired formation of cortical layers, and abnormal calcium signaling and neural network activity. [Cell Rep Med] Full Article | Graphical Abstract Subscribe to one of our other 19 science newsletters such as Cell Therapy News & Mesenchymal Cell News. | |
| |
REVIEWSExpression and Function of CartilageDerived Pluripotent Cells in Joint Development and Repair Scientists focus on the organizational distribution, expression, and function of cartilage-derived pluripotent cells in joint development and repair to help explore the therapeutic potential of in situ cartilage-derived pluripotent cells for joint cartilage repair. [Stem Cell Res Ther] Full Article Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field. | |
| |
INDUSTRY NEWSAgeX Therapeutics, Inc. announced that ImStem Biotechnology, Inc. has received notification from the FDA that it has lifted the hold and cleared the Investigational New Drug application to evaluate IMS001 for the treatment of multiple sclerosis. [AgeX Therapeutics, Inc.] Press Release | |
| |
POLICY NEWSResearchers Are Tracking Another Epidemic, Too—of Misinformation When five researchers at the University of Washington, Seattle, launched the new Center for an Informed Public back in December 2019, they had no idea what was coming. The center aims to study how misinformation propagates and use the findings to “promote an informed society, and strengthen democratic discourse. Now, just a few months later, the coronavirus pandemic is generating a tidal wave of information—some of it accurate, some not so much—that has saturated social and traditional media.” [ScienceInsider] Editorial After Conference Cancellations, Some Scientists Find a Way As scores of academic meetings get upended due to COVID-19, researchers are turning to virtual replacements. [The Scientist] Editorial
| |
EVENTSIn light of COVID-19, many conferences are being cancelled or postponed. As such: We are suspending new event postings in our newsletters and on Twitter. Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Fellows – Developmental Neuroscience (Children’s National Hospital) NEW Researcher – iPSCs (European Molecular Biology Laboratory) Technician – Stem Cell Culture (University of Luxembourg) Postdoctoral Position – Pluripotency (Cancer Research Center) Research Specialist – Stem Cells for Regenerative Medicine (University of Illinois at Chicago) Postdoctoral Associate – Cerebral Organoids (Weill Cornell Medicine) Assistant Specialist – Division of Cardiovascular Medicine (University of California, Davis) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in ESC & iPSC News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|